K T Hogan - JoVE Visualize

Showing results (11-20 of 20) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 20 results.

Journal of Biological Response Modifiers|August 1, 1985

Effects of tumor status on the regulation of natural killer cell activity by tumor-associated fetal antigensK T Hogan, D T Harris, S R Plunkett, et al.

Developmental and Comparative Immunology|January 1, 1984

Nonspecific cytotoxic cells in fish (Ictalurus punctatus). III. Biophysical and biochemical properties affecting cytolysisD L Evans, K T Hogan, S S Graves, et al.

The Journal of Experimental Medicine|August 1, 1988

Mutations in the alpha 2 helix of HLA-A2 affect presentation but do not inhibit binding of influenza virus matrix peptideK T Hogan, N Shimojo, S F Walk, et al.

Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1987

The ability of cytotoxic T cells to recognize HLA-A2.1 or HLA-B7 antigens expressed on murine cells correlates with their epitope specificityE J Bernhard, A X Le, J R Yannelli, et al.

Journal of Immunology (Baltimore, Md. : 1950)|March 15, 1989

A panel of unique HLA-A2 mutant molecules define epitopes recognized by HLA-A2-specific antibodies and cytotoxic T lymphocytesK T Hogan, C Clayberger, E J Bernhard, et al.

Journal of Immunology (Baltimore, Md. : 1950)|October 1, 1988

Identification by site-directed mutagenesis of amino acid residues contributing to serologic and CTL-defined epitope differences between HLA-A2.1 and HLA-A2.3K T Hogan, C Clayberger, E J Bernhard, et al.

Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1988

Cytotoxic T lymphocyte-defined epitope differences between HLA-A2.1 and HLA-A2.2 map to two distinct regions of the moleculeK T Hogan, C Clayberger, A X Le, et al.

Journal of Immunology (Baltimore, Md. : 1950)|December 23, 1998

HLA (A*0201) mimicry by anti-idiotypic monoclonal antibodiesW J Burlingham, E Jankowska-Gan, L DeVito-Haynes, et al.

Human Immunology|July 1, 1993

Epitope fine specificity of human anti-HLA-A2 antibodies. Identification of four epitopes including a haptenlike epitope on HLA-A2 at lysine 127L D De Vito, B P Mason, E Jankowska-Gan, et al.

Cancer Research|November 21, 1998

The peptide recognized by HLA-A68.2-restricted, squamous cell carcinoma of the lung-specific cytotoxic T lymphocytes is derived from a mutated elongation factor 2 geneK T Hogan, D P Eisinger, S B Cupp, et al.

Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 20 results.

Journal of Biological Response Modifiers|August 1, 1985

Effects of tumor status on the regulation of natural killer cell activity by tumor-associated fetal antigensK T Hogan, D T Harris, S R Plunkett, et al.

Developmental and Comparative Immunology|January 1, 1984

Nonspecific cytotoxic cells in fish (Ictalurus punctatus). III. Biophysical and biochemical properties affecting cytolysisD L Evans, K T Hogan, S S Graves, et al.

The Journal of Experimental Medicine|August 1, 1988

Mutations in the alpha 2 helix of HLA-A2 affect presentation but do not inhibit binding of influenza virus matrix peptideK T Hogan, N Shimojo, S F Walk, et al.

Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1987

The ability of cytotoxic T cells to recognize HLA-A2.1 or HLA-B7 antigens expressed on murine cells correlates with their epitope specificityE J Bernhard, A X Le, J R Yannelli, et al.

Journal of Immunology (Baltimore, Md. : 1950)|March 15, 1989

A panel of unique HLA-A2 mutant molecules define epitopes recognized by HLA-A2-specific antibodies and cytotoxic T lymphocytesK T Hogan, C Clayberger, E J Bernhard, et al.

Journal of Immunology (Baltimore, Md. : 1950)|October 1, 1988

Identification by site-directed mutagenesis of amino acid residues contributing to serologic and CTL-defined epitope differences between HLA-A2.1 and HLA-A2.3K T Hogan, C Clayberger, E J Bernhard, et al.

Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1988

Cytotoxic T lymphocyte-defined epitope differences between HLA-A2.1 and HLA-A2.2 map to two distinct regions of the moleculeK T Hogan, C Clayberger, A X Le, et al.

Journal of Immunology (Baltimore, Md. : 1950)|December 23, 1998

HLA (A*0201) mimicry by anti-idiotypic monoclonal antibodiesW J Burlingham, E Jankowska-Gan, L DeVito-Haynes, et al.

Human Immunology|July 1, 1993

Epitope fine specificity of human anti-HLA-A2 antibodies. Identification of four epitopes including a haptenlike epitope on HLA-A2 at lysine 127L D De Vito, B P Mason, E Jankowska-Gan, et al.

Cancer Research|November 21, 1998

The peptide recognized by HLA-A68.2-restricted, squamous cell carcinoma of the lung-specific cytotoxic T lymphocytes is derived from a mutated elongation factor 2 geneK T Hogan, D P Eisinger, S B Cupp, et al.

Pageof 2